Six months ago, I wrote about pharmaceutical companies’ use of twitter. At the time, only 4 big pharmacos were experimenting with this new communication channel.
Over these past months, I have seen these companies (and others that followed since) gather insight and savvy into their use of twitter. It is thus time to look beyond the mere fact that pharmacos ARE using twitter and to analyze the finer details of HOW they are using it.
My next 3-4 blog posts will therefore be dedicated to the “pharma twittersphere“. In particular, I will be looking at:
1. who pharmacos reach with twitter and the differences between companies
2. how they participate (or not) in the twitter conversation
3. how they could take twitter to the next level in terms of topics and collaboration.
As you can see below, this last question is very much on Boehringer’s and Roche’s minds as well.
I therefore will start of my “state of the pharma twittersphere” by asking for your help. Please answer the following three questions as an input to my analysis:
Loading ... Loading ... Loading ...I look forward to your thoughts and input. As always, feel free to also use the comment section to elaborate on your thoughts 
7 Comments on "The state of the pharma twittersphere"
I look forward to your next posts on this subject, but I also think it would be very interesting to see what people who use the products made by our companies are looking for — is it customer service? Advice? or just the latest information?
I am very much looking forward to your posts – I hope that answering the questions help.
Yes, that is indeed the million dollar question
My guess would be all of the above.
People are active on twitter, because they want the interaction. The follow you, because they want to interact with you and your brand- how do you turm this interaction into a lasting positive customer experience?
Thank you so much for your participation. Your input is highly appreciated
Trackbacks for this post